Lessons from Developed Jurisdictions on Balancing IP Rights and Competition Law

Intellectual property rights and competition law are often seen as being at odds with each other. IP rights grant exclusive control to creators and innovators – a deliberate, time-limited monopoly meant to incentivize investment in new ideas. Competition law, on the other hand, works to prevent exactly that kind of market dominance from harming consumers and rivals. So how do developed legal systems manage this tension without letting one undermine the other? The experiences of the United States and the European Union offer two of the most instructive models in the world, each shaped by distinct legal traditions, enforcement philosophies, and landmark cases.

The underlying conflict: IP rights vs. open markets 🔗

At first glance, IP law and competition law appear to pursue opposite goals. A patent holder, for instance, legally has the right to prevent anyone else from using their invention – that is precisely the point of a patent. But if the patent covers a technology that competitors cannot practically work without, that exclusivity can stifle competition and harm the market. As the U.S. Federal Trade Commission has articulated, both bodies of law share the deeper objective of encouraging innovation and enhancing consumer welfare – the tension arises in application, not purpose. The challenge, then, is to build a legal framework that preserves incentives for innovation without allowing IP rights to become vehicles for anticompetitive behaviour.

The United States approach 🔗

From adversaries to complements 🔗

The U.S. legal system has evolved considerably in how it treats the relationship between IP rights and antitrust law. For much of the twentieth century, courts took a suspicious view of IP licensing arrangements, treating many of them as presumptively anticompetitive. That changed dramatically over the following decades. A pivotal moment came with the 1990 Federal Circuit decision in Atari Games Corp. v. Nintendo of America, Inc., which stated that patent and antitrust laws, while seemingly at odds, are in fact complementary – both aimed at encouraging innovation, industry, and competition.

This shift in judicial thinking paved the way for more nuanced enforcement. The U.S. antitrust agencies – the Department of Justice (DOJ) and the Federal Trade Commission (FTC) – jointly issued Antitrust Guidelines for the Licensing of Intellectual Property first in 1995, and most recently updated in 2017. These guidelines are foundational to how the U.S. manages the IP-competition interface.

The IP Licensing Guidelines: key principles 🔗

The 2017 IP Licensing Guidelines rest on three core principles. First, the agencies treat IP as a form of property like any other – having an IP right does not automatically imply unlawful market power. Second, the mere existence of an IP right is not presumed to confer the kind of market dominance that antitrust law targets. Third, IP licensing is generally viewed as procompetitive, since it allows technology to flow to those who can use it most effectively.

When evaluating any licensing arrangement, the DOJ and FTC apply what is known as the rule of reason: they ask first whether a restraint adversely affects competition, and if so, whether its procompetitive benefits outweigh those harms. Only licensing arrangements that are facially anticompetitive – those that almost always tend to reduce output or raise prices – are treated as per se violations. Most others pass through the rule of reason analysis.

The guidelines also establish a safety zone: if the parties together hold less than 20% of the relevant market, the arrangement is unlikely to attract antitrust scrutiny. This provides businesses with meaningful legal certainty when structuring their licensing deals.

Specific areas of concern: patent pools, grantbacks, and refusals to license 🔗

The guidelines address several licensing practices in detail. Patent pooling – where multiple rights holders combine their patents and license them collectively – is generally viewed as procompetitive because it reduces transaction costs and makes technology more accessible. However, if the pool involves competitors with collective market power, it can also raise price-fixing concerns and draws closer scrutiny.

Grantback clauses, which require a licensee to share improvements back to the licensor, present a more nuanced picture. Non-exclusive grantbacks are typically acceptable because the licensee remains free to license those improvements to others. Exclusive grantbacks, however, can reduce the licensee’s incentive to innovate and may be found anticompetitive.

The question of refusals to license is especially contested in the U.S. context. Unlike the EU (as discussed below), U.S. antitrust law generally does not recognize a standalone claim for “abuse of dominance.” A patent or copyright holder’s refusal to deal with rivals is typically treated as a legitimate exercise of their statutory right to exclude, unless it is found to be a pretextual effort to harm competition – a standard set out in cases like Image Technical Services, Inc. v. Kodak Co. (Ninth Circuit, 1997), which has been influential though not widely followed.

The European Union approach 🔗

A more interventionist framework 🔗

The EU starts from a broadly similar premise – that IP licensing is generally procompetitive – but arrives at its conclusions through a more regulatory and prescriptive structure. The central legislative tool is the Technology Transfer Block Exemption Regulation (TTBER), currently governed by Commission Regulation (EU) No. 316/2014, which operates under Article 101 of the Treaty on the Functioning of the European Union (TFEU). Article 101 prohibits agreements that restrict competition, but Article 101(3) allows exemptions where the procompetitive benefits outweigh the harms.

The TTBER creates a safe harbour – a pre-cleared zone where technology licensing agreements are automatically exempt from competition law scrutiny, provided they meet certain conditions. The key conditions relate to market share thresholds: agreements between competing firms are exempt if their combined market share does not exceed 20%, and agreements between non-competitors are exempt where individual shares do not exceed 30%. These thresholds reflect the logic that lower market power means lower risk of competitive harm from licensing restrictions.

Hardcore restrictions and the limits of the safe harbour 🔗

The TTBER does not grant blanket protection. Certain practices – called hardcore restrictions – are so damaging to competition that they exclude the entire agreement from the safe harbour. These include price-fixing between competitors, market sharing, and passive sales restrictions between licensees. Any licensing agreement containing such clauses cannot benefit from the TTBER exemption, regardless of the parties’ market shares.

Following an evaluation process, the European Commission published a revised draft TTBER in September 2025 for consultation, with the current TTBER set to expire in April 2026. The revised rules aim to clarify how market shares are calculated in technology markets, extend the grace period after parties exceed market share thresholds from two to three years, and introduce new guidance on technology pools and licensing negotiation groups (LNGs) – where potential licensees collectively negotiate terms with a licensor, a practice that has grown in significance particularly in the automotive and technology sectors.

Article 102 TFEU and the abuse of dominant position 🔗

While Article 101 governs agreements between parties, Article 102 TFEU prohibits abusive conduct by dominant undertakings – acting unilaterally. This is where the EU diverges most sharply from the U.S. In particular, EU law imposes a special responsibility on dominant firms not to foreclose competitors, and this applies directly to the exercise of IP rights.

The landmark case is RTE & ITP v. Commission, commonly known as the Magill case (1995), where Irish television broadcasters used copyright law to prevent a publisher from compiling a comprehensive weekly TV guide – information no single broadcaster offered. The European Court of Justice held that this refusal to license was an abuse under what was then Article 82 of the EC Treaty (now Article 102 TFEU). The court did not say that IP holders must always license – rather, it held that a refusal to license by a dominant firm can constitute abuse in exceptional circumstances.

The IMS Health case (2004) refined this further. The court laid down a four-part test: a refusal to license is abusive only if it eliminates all competition in a downstream market, access to the IP is indispensable, there is no objective justification for the refusal, and the refusal prevents the emergence of a new product for which consumer demand exists. This four-element cumulative test – derived from Magill and confirmed in IMS Health – remains the cornerstone of EU law on compulsory IP licensing.

Perhaps the most consequential application of these principles came in the Microsoft case (2007). The European Commission found that Microsoft abused its dominant position by refusing to supply interoperability information to competitors in the work group server market – information that rivals needed to ensure their products could communicate effectively with Windows operating systems. The Commission imposed a fine of €497 million and required Microsoft to disclose accurate interface documentation to allow developers to compete effectively. When Microsoft failed to comply, the General Court eventually fixed additional penalties at €860 million – underscoring the EU’s willingness to use substantial enforcement power against IP-related market abuses.

Comparing the two systems: key differences and shared lessons 🔗

The U.S. and EU approaches share a foundational belief that IP and competition law are not inherently opposed. Both systems treat licensing as generally procompetitive, apply market-power analysis before intervening, and avoid treating every IP-related restriction as an automatic violation. However, they diverge meaningfully in enforcement philosophy and threshold.

In the U.S., the starting presumption strongly favours the IP holder’s right to refuse dealing. The antitrust bar for challenging a refusal to license is high, and there is no formal doctrine of abuse of dominance for single-firm conduct. In the EU, dominant firms carry a special responsibility not to foreclose competition – and in exceptional cases, can be compelled to license their IP to rivals. The EU’s TTBER also creates a more structured and codified safe harbour compared to the more discretionary U.S. guidelines.

From the perspective of a developing jurisdiction like India – which is still refining the relationship between its IP laws and the Competition Act, 2002 – both models offer important insights. The U.S. experience suggests that clear, principle-based guidelines issued by enforcement agencies can provide substantial legal certainty without stifling innovation. The EU’s experience demonstrates that structured block exemptions combined with a robust abuse-of-dominance doctrine can effectively prevent dominant IP holders from using their rights to exclude competitors in ways that harm consumers. India’s own jurisprudence, particularly cases involving standard essential patents and pharmaceutical licensing, reflects a growing awareness of these international precedents as it works toward a coherent domestic framework.

Why this matters for law students and practitioners in India 🔗

Understanding how the U.S. and EU handle the IP-competition interface is not just an academic exercise. As India’s technology and pharmaceutical sectors grow and as the Competition Commission of India (CCI) handles increasingly complex IP-related cases, practitioners need to be fluent in international benchmarks. The U.S. DOJ-FTC IP Licensing Guidelines and the EU’s TTBER framework are reference points that Indian courts and regulators already look to when reasoning through novel cases. Knowing not just what these frameworks say, but why they developed the way they did – and what trade-offs each reflects – equips you to engage with these questions at the highest level.

What do you think? The EU’s approach allows competition law to override IP rights in “exceptional circumstances” through compulsory licensing – while the U.S. keeps that bar far higher. Which model better balances innovation incentives with market fairness, and should India lean toward one of these frameworks as it develops its own jurisprudence on IP and competition? Also, given that both systems are currently updating their rules – the U.S. in 2017 and the EU with its TTBER revision in 2025-2026 – what does that tell us about the inherently evolving nature of this balance?

References

1. https://www.ftc.gov/news-events/news/speeches/antitrust-intellectual-property-law-adversaries-partners
2. https://www.justice.gov/atr/IPguidelines/dl
3. https://eur-lex.europa.eu/EN/legal-content/summary/ensuring-technology-transfer-agreements-respect-competition-rules.html
4. https://www.gtlaw.com/en/insights/2025/10/european-commission-publishes-revised-eu-competition-rules-for-technology-transfer-agreements
5. https://competition-policy.ec.europa.eu/antitrust-and-cartels/legislation/application-article-102-tfeu_en
6. https://www.lexology.com/library/detail.aspx?g=7d121141-f763-470b-bb04-20454fa881bf
7. https://ceelegalmatters.com/slovenia/11922-unilateral-refusal-to-license-intellectual-property-rights-in-eu-competition-law
8. https://competition-policy.ec.europa.eu/antitrust-and-cartels/legislation/block-exemption-regulations/ttber_en